¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cytokine Receptor Common beta Subunit"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® receptor ÇÑ±Û ¼ö¿ëü
¼³¸í   
  ¼¼Æ÷Áú³» ¶Ç´Â ¼¼Æ÷Ç¥¸é¿¡ Á¸ÀçÇϴ ºÐÀÚ±¸Á¶·Î¼­ Æ¯À̹°Áú°ú ¼±ÅÃÀûÀ¸·Î °áÇÕÇϸ砰áÇÕ¿¡ ÀÇÇØ Æ¯ÀÌÇÑ »ý¸®Àû ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÆéƼµåÈ£¸£¸ó, ½Å°æÀü´Þ¹°Áú, Ç׿ø, º¸Ã¼, ¸é¿ª±Û·ÎºÒ¸°¿¡ ´ëÇÑ ¼¼Æ÷Ç¥¸é ¼ö¿ëü¿Í ½ºÅ×·ÎÀ̵忡 ´ëÇÑ ¼¼Æ÷Áú³» ¼ö¿ëü°¡ ÀÖ´Ù.
¿µ¹® cytokine ÇÑ±Û ½ÃÅäÄ«ÀÎ
¼³¸í   
  Á¶Á÷ÀÇ ±¹¼Ò¿¡¼­ »ý»êµÇ¾î¼­ ±¹¼ÒÀÇ ¼¼Æ÷°£ÀÇ ½ÅÈ£Àü´ÞÀ» ¸Å°³Çϴ ´Ü¹éÁú ÀÎÀÚÀÇ ÃÑĪÀÌ´Ù. Ç¥Àû¼¼Æ÷ÀÇ ¼ö¿ëü¿¡ °áÇÕÇØ¼­ ¼¼Æ÷³» È°¼ºÈ­ ¸ÞÄ¿´ÏÁòÀ» ¹ßÇö½Ã۴ °ÍÀ¸·Î ¸é¿ª¹ÝÀÀÀÇ Á¦¾î, Ç×¾ÏÀÛ¿ë, Ç×¹ÙÀÌ·¯½ºÀÛ¿ë, ¼¼Æ÷ÀÇ Áõ½Ä-ºÐÈ­ÀÇ Á¶Àý µîÀÇ ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÀϹÝÀûÀ¸·Î 10£­12~10£­10 ¸ôÀÇ ±ØÈ÷ ¹Ì·®¿¡¼­ ±â´ÉÇϸ砽żÓÈ÷ ºÐÇØ¼Ò½ÇµÈ´Ù. ¸²ÇÁ±¸°¡ ºÐºñÇϴ ¸²Æ÷Ä«ÀÎ, Å«Æ÷½Ä¼¼Æ÷ À¯·¡ÀÇ ¸ð³ëÄ«ÀÎ, T¼¼Æ÷°¡ ºÐºñÇϴ ÀÎÅÍ·çŲ µîÀÇ ¿©·¯ Á¾·ù°¡ ¾Ë·ÁÁö°í ÀÖÀ¸³ª °¢°¢ÀÇ À¯ÀüÀÚÀÇ ÇØ¸íÀ¸·Î µ¿ÀÏÇÑ °ÍÀÌ ÆÇ¸íµÇ°í ÀÖ´Ù.
¿µ¹® beta human chorionic gonadotropin ÇÑ±Û º£Å¸ »ç¶÷À¶¸ð¼º »ý½Ä»ùÀÚ±ØÈ£¸£¸ó
¼³¸í   
  Å¹ݼ¼Æ÷¿¡¼­ ¸¸µé¾îÁö´Â È£¸£¸ó. ±â´ÉÀº ÀÓ½ÅÀÇ Ãʱ⿡ È²Ã¼(¿ø·¡ ³­ÀÚ¸¦ ½Î°í ÀÖ´ø ¼¼Æ÷µéÀÌ ¹è¶õÀÌ ÀϾ¼­ ³­ÀÚ°¡ ºüÁ®³ª°£ ÈÄ ÁÖ¸Ó´Ï ¸ð¾çÀ» ÀÌ·é °Í. ÀÓ½ÅÃʱ⿡ ÀÓ½ÅÀÇ À¯Áö¿¡ ÇÊ¿äÇѠȣ¸£¸óÀ» »ý¼ºÇÑ´Ù)ÀÇ À¯Áö¿¡ ±â¿©Çϰí, Å¾ÆÀÇ °íȯÁ¶Á÷¿¡¼­ ³²¼ºÈ£¸£¸óÀÌ ºÐºñµÇ´Â °ÍÀ» ÃËÁø½ÃŲ´Ù. ¶Ç À̰ÍÀº ÀÓ½ÅÃʱâÀÇ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼­ ¸¹Àº ¾çÀÌ °ËÃâµÇ¹Ç·Î À̰ÍÀ» ÀÌ¿ëÇØ¼­ ÀÓ½ÅÀÇ ¿©ºÎ¸¦ ¼Õ½±°Ô Á¶»çÇÒ ¼ö°¡ ÀÖ´Ù.
¿µ¹® beta ray ÇÑ±Û º£Å¸¼±
¼³¸í   
  ¹æ»ç¼º ¿øÀÚÇÙÀÌ ¥âºØ±«ÇÔ¿¡ µû¶ó ¹æÃâµÇ´Â ¹æ»ç¼±. ¿øÀÚ¿¡ Á¤»óº¸´Ù ¸¹°Å³ª ÀûÀº Áß¼ºÀÚ³ª ¾çÀÚ¸¦ °¡Áö°í Àִ °æ¿ì¿¡´Â ¿øÀÚ°¡ ¾ÈÁ¤µÇ±â À§ÇÏ¿© ºØ±«°¡ ¼¼°¡Áö ¹æ¹ýÀ¸·Î »ý±ä´Ù. ÀÌÁß Áß¼ºÀÚ°¡ ÇϳªÀÇ ÀüÀÚ¸¦ ³»°í ¾ç¼ºÀÚ°¡ µÇ´Â º¯È­¸¦ °ÅÄ¡¸é¼­ ³ª¿À´Â ÀüÀÚ¼±ÀÌ´Ù. ±× ½Çü´Â °í¼ÓÀÇ ÀüÀÚ ¶Ç´Â ¾çÀüÀÚÀ̸ç ÃÖ´ë ¿¡³ÊÁö´Â 105-107eV. Åõ°ú·Â ¹× ÀÌ¿ÂÈ­ ÀÛ¿ëÀº ¥á¼±°ú ¥ã¼±ÀÇ Áß°£ Á¤µµÀÌ´Ù.
¿µ¹® beta-blocker ÇÑ±Û º£Å¸Â÷´ÜÁ¦
¼³¸í   
  º£Å¸-¼ö¿ëü(1°ú 2¿¡ °ü°è¾øÀÌ)ÀÇ ±â´ÉÀ» ¾ïÁ¦½Ã۴ ¾à¹°·Î ÀÌ ¼ö¿ëü°¡ ¸Å°³ÇÏ¿© »ý±â´Â ½ÅüÀÇ º¯È­¸¦ ¾ïÁ¦ÇÑ´Ù. PropranololÀÌ ÁÁÀº ¿¹ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈ­È¿¼Ò
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • cytokine network
    ½ÃÅäÄ«Àα׹°, ½ÃÅäÄ«ÀÎ³×Æ®¿öÅ©
  • subunit
    ¼Ò´ÜÀ§, ÇϺδÜÀ§
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • beta cell
    º£Å¸¼¼Æ÷
  • beta counting
    º£Å¸°è¼ö
  • beta emitter
    º£Å¸¹æÃâü
  • beta error
    º£Å¸¿À·ù, Á¦2Çü¿À·ù
  • beta hemolysis
    º£Å¸¿ëÇ÷, ¿ÏÀü¿ëÇ÷
  • beta particle
    º£Å¸ÀÔÀÚ
  • beta ray
    º£Å¸¼±
  • beta-carotene
    º£Å¸Ä«·Îƾ
  • beta-lactam
    º£Å¸¶ôŽ
  • beta-lactamase
    º£Å¸¶ô޾ÆÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • subunit
    ¼Ò´ÜÀ§, ¹Ø´ÜÀ§
  • common carotid artery
    ¿Â¸ñµ¿¸Æ
  • common
    °øµ¿-, º¸Åë-, ¿Â-
  • common bile duct
    ¿Â¾µ°³°ü, ÃÑ´ã°ü
  • beta-carotene
    º£Å¸Ä«·Îƾ
  • beta cell
    º£Å¸¼¼Æ÷
  • beta hemolysis
    º£Å¸¿ëÇ÷
  • beta ray
    º£Å¸¼±
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor
    ¼ö¿ëü, ¼ö¿ë±â
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • opiate receptor
    ¾ÆÆí¼ö¿ëü
  • sensory receptor
    °¨°¢¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • subunit
    ¼Ò´ÜÀ§, ¹Ø´ÜÀ§
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • beta cell
    º£Å¸¼¼Æ÷
  • beta counting
    º£Å¸°è¼ö
  • beta emitter
    º£Å¸¹æÃâ±â
  • beta error
    Á¦ÀÌÁ¾¿À·ù
  • beta hemolysis
    º£Å¸¿ëÇ÷, ¿ÏÀü¿ëÇ÷
  • beta particle
    º£Å¸ÀÔÀÚ
  • beta ray
    º£Å¸¼±
  • common antigen
    °øÅëÇ׿ø
  • common carotid artery
    ¿Â¸ñµ¿¸Æ
  • common hepatic artery
    ¿Â°£µ¿¸Æ
  • common iliac artery
    ¿Â¾ûµ¢µ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cytokine
    »çÀÌÅäÄ«ÀÎ
  • Final common path
    ÃÖÁ¾(õÌðû)°øÅë(Íì÷×)Åë·Î(÷×ÖØ)
  • proximal common pathway
    ±ÙÀ§°øÅë°æ·Î.
  • 11-beta-hydroxylase
    11-º£Å¸-¼ö»êÈ­È¿¼Ò, 11-º£Å¸-È÷µå·Ï½Ç¶óÁ¦
  • 3-beta-hydroxysteroid dehydrogenase
    3-º£Å¸-È÷µå·Ï½Ã½ºÅ×·ÎÀ̵å Å»¼ö¼ÒÈ¿¼Ò
  • O-Nitrophenyl-beta-galactoside => ONPG
    O-´ÏÆ®·ÎÆä´Ò-º£Å¸-°¥¶ôÅä½Ãµå
  • acetyl-beta-methylcholine
    ¾Æ¼¼Æ¿-º£Å¸-¸ÞÆ¿Äݸ°
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
  • gamma-delta-beta thalassemia
    °¨¸¶-µ¨Å¸-º£Å¸- ÁöÁßÇØ¼ººóÇ÷
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • A1 receptor
    A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • A2 receptor
    A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • CR1 => complement receptor 1
    º¸Ã¼¼ö¿ëü 1
  • CR2 => complement receptor 2
    º¸Ã¼¼ö¿ëü 2
  • CR3 => complement receptor 3
    º¸Ã¼¼ö¿ëü 3
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-ARK : beta-adrenergic receptor kinase
    º£Å¸-¾Æµå·¹³¯¸°(¼º)¼ö¿ëü ÀλêÈ­È¿¼Ò.
  • cytokine
    »çÀÌÅäÄ«ÀÎ, ¼¼Æ÷È£¸£¸ó.
  • cytokine
    »çÀÌÅäÄ«ÀÎ
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • influenza subunit vaccine
    ÀÎÇ®·ç¿£ÀÚ ¾Æ´ÜÀ§¹é½Å
  • subunit
    ¾Æ´ÜÀ§, ¼Ò´ÜÀ§
  • subunit vaccine
    ¾Æ´ÜÀ§ ¹é½Å
  • vaccine, subunit
    ¾Æ´ÜÀ§ ¹é½Å
  • beta adrenergic receptor
    º£Å¸¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼öü)
  • beta receptor
    º£Å¸ ¼ö¿ëü(¼ö¿ë±â, °¨¼öü, °¨¼ö±â)
  • beta receptor blocker
    º£Å¸¼ö¿ëü Â÷´ÜÁ¦( -áôé»ô÷ ó´Ó¨ð¥)
  • beta receptor stimulating agent
    º£Å¸¼ö¿ëü ÀÚ±ØÁ¦( -áôé»ô÷ í©Ð½ð¥)
  • beta-adrenergic receptor
    º£Å¸ ¾Æµå·¹³¯¸°¼º ¼ö¿ëü
  • acetyl-beta-methylcholine
    ¾Æ¼¼Æ¿-º£Å¸-¸ÞÆ¿Äݸ°
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Beta cell [Insulin cell]
    º£Å¸¼¼Æ÷ [Àν´¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] º£Å¸¼¼Æ÷
  • Receptor
    ¼ö¿ë±â
    [¿¾ ¿ë¾î] ¼ö¿ë±â
  • Common synovial sheath of flexors of fingers
    (¼Õ°¡¶ô)±ÁÈû±Ù¿ÂÈûÁÙÁý
    [¿¾ ¿ë¾î] (¼ö)Áö±¼±ÙÃѰÇÃÊ
  • Common hepatic duct
    ¿Â°£°ü
    [¿¾ ¿ë¾î] ÃѰ£°ü
  • Common hepatic artery
    ¿Â°£µ¿¸Æ
    [¿¾ ¿ë¾î] ÃѰ£µ¿¸Æ
  • Common cardinal vein
    ¿Â±âº»Á¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÁÖÁ¤¸Æ
  • Common dorsal mesentery
    ¿ÂµîÂÊâÀÚ°£¸·
    [¿¾ ¿ë¾î] ÃѹèÃøÀå°£¸·
  • Common carotid artery
    ¿Â¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ(°£)
  • Common carotid artery (partial)
    ¿Â¸ñµ¿¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ
  • Common carotid plexus
    ¿Â¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ½Å°æÃÑ
  • Common basal vein
    ¿Â¹Ù´ÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÆóÀúÁ¤¸Æ
  • Common plantar digital arteries
    ¿Â¹Ù´ÚÂʹ߰¡¶ôµ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑ̫̿Áöµ¿¸Æ
  • Common plantar digital nerves
    ¿Â¹Ù´ÚÂʹ߰¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ÃÑ̫̿Áö½Å°æ
  • Common palmar digital arteries
    ¿Â¹Ù´ÚÂʼհ¡¶ôµ¿¸Æ
    [¿¾ ¿ë¾î] ÃÑÀåÃøÁöµ¿¸Æ
  • Common palmar digital nerves
    ¿Â¹Ù´ÚÂʼհ¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ÃÑÀåÃøÁö½Å°æ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • common vehicle
    °øÅë¸Å°³Ã¼
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • common intermediate principle
    °øÅë Áß°£Ã¼¿ø¸®(Íì÷×ñéÊàô÷ê«×â)
  • cytokine
    »çÀÌÅäÄ«ÀÎ
  • beta adrenergic receptor
    º£Å¸ ¾Æµå·¹³¯¸° ¼ö¿ëü(áôé»ô÷)
  • beta receptor
    º£Å¸ ¼ö¿ëü(áôé»ô÷)
  • catalytic subunit
    Ã˸žƴÜÀ§(õºØÚä¬Ó¤êÈ)
  • proteoglycan subunit
    ÇÁ·ÎÅ׿À±Û¶óÀÌÄ­ ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • regulatory subunit
    Á¶Àý ¾Æ´ÜÀ§(ðàï½ä¬Ó¤êÈ)
  • ribosomal subunit
    ¶óÀ̺¸¼Ø ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • ribosomal subunit exchange
    ¶óÀ̺¸¼Ø ¾Æ´ÜÀ§(ä¬Ó¤êÈ) ±³È¯(Îßüµ)
  • subunit
    ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • subunit exchange
    ¾Æ´ÜÀ§ ±³È¯(ä¬Ó¤êÈÎßüµ)
  • subunit model
    ¾Æ´ÜÀ§(ä¬Ó¤êÈ) ¸ðµ¨
  • adrenergic receptor
    ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) ¼ö¿ëü(áôé»ô÷)
  • alpha adrenergic receptor
    ¾ËÆÄ¾Æµå·¹³ª¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷)
  • alpha receptor
    ¾ËÆÄ¼ö¿ëü(áôé»ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â, ¼ö¿ëü, °¨¼öü
  • beta
    º£Å¸
  • beta blocker
    º£Å¸Â÷´ÜÁ¦
  • CGI(common gateway interface)
    CGI
  • common atrioventricular canal
    °øÅë¹æ½Ç°ü
  • common bile duct
    ÃÑ´ã°ü
  • common carotid artery
    ÃѸñµ¿¸Æ, ÃѰ浿¸Æ
  • common cold
    °¨±â
  • common hepatic artery
    ÃѰ£µ¿¸Æ
  • common iliac artery
    ÃÑÀå°ñµ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CRF case report form; chronic renal failure; chronic respiratory failure; coagulase-reacting factor; con...
CSIF cytokine synthesis inhibitory factor
CMR cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c...
HCPCS Health Care Financing Administration common procedural collecting system; Health Care Financing Admi...
CDPS calcium-dependent protease small subunit
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
beta HCG beta subunit of human chorionic gonadotrophin
G beta G protein beta subunit
beta C beta subunit
HCG beta human chorionic gonadotrophin beta subunit
CINC 8/cytokine-induced neutrophil chemoattractant
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • beta-aminoisobutyric aciduria ¿äÁß¿¡ º£Å¸-¾Æ¹Ì³ë ¾ÆÀ̼ҴлêÀÌ °úµµ·Î ¹è¼³µÇ´Â °Í. ¾ç¼ºÀÇ À¯Àü¼º ´ë»ç¼º ÀÌ»óÀ¸·Î ÀϾ¸ç ±×¸®°í ƯÁ¤ÇÑ Áúȯ¿¡¼­µµ ³ªÅ¸³­´Ù.

    beta-arrestin

    º£Å¸-¾î·¹½ºÆ¾
  • subunit
    ¾Æ´ÜÀ§
  • beta receptor blocker
    º£Å¸ ¼ö¿ëü Â÷´ÜÁ¦
  • common
    ÀϹÝÇü
  • common atrioventricular canal
    °øÅë ¹æ½Ç°ü
  • common bile duct
    ÃÑ ´ã°ü
  • common carotid artery
    ÃÑ ¸ñµ¿¸Æ, ÃÑ °æµ¿¸Æ
    µÎ°æºÎ¿¡ ºÐÆ÷ÇÏ´Â µ¿¸ÆÀÇ ÁÖµÈ °¡Áö·Î ¿ì´Â ¿ÏµÎµ¿¸Æ¿¡¼­ Á´ ´ëµ¿¸Æ±Ã¿¡¼­ °¢°¢ ºÐ±âÇÏ¿© ±â°ü°ú ÈĵÎÀÇ ¿ÜÃøÀ» Áö³ª¼­ »óÇàÇÏ¿© °©»ó ¿¬°ñ »ó¿¬ÀÇ ³ôÀÌ¿¡¼­ ³»°æµ¿¸Æ°ú ³»°æµ¿¸ÆÀ¸·Î ³ª´µ¾îÁø´Ù.
  • common carotid plexus
    ¿Â¸ñ µ¿¸Æ ½Å°æ ¾ó±â, ÃÑ °æµ¿¸Æ ½Å°æÃÑ
  • common drug
    º¸Åë ¾à
  • common facial vein
    ¿Â ¾ó±¼ Á¤¸Æ, ÃѾȸé Á¤¸Æ
  • common feature
    ÀϹÝÀûÀÎ ¼Ò°ß
  • common iliac artery
    ÃÑÀå°ñ µ¿¸Æ
  • common interosseous artery
    ÃÑ»À »çÀÌ µ¿¸Æ, ÃѰñ°£ µ¿¸Æ
  • common migraine
    ÀÏ¹Ý ÆíµÎÅë, ÀϹÝÀûÀÎ ÆíµÎÅë, ÀϹÝÀû ÆíµÎÅë, ÀϹÝÇü ÆíµÎÅë
    migraine without aura¸¦ º¸½Ã¿À.
  • common mole
    ½É»ó ¸ð¹Ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
chorionic gonadotropin, beta subunit, human The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (scan j clin lab invest suppl 1993;216:97-104)
(12 Dec 1998)
receptors, cytokine Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
cytokine <biochemistry> Small proteins or biological factors (in the range of 5-20 kD) that are released by cells and have specific effects on cell-cell interaction, communication and behaviour of other cells.
Not really different from hormones, but the term tends to be used as a convenient generic shorthand for interleukins, lymphokines and several related signalling molecules such as TNF and interferons.
Generally growth factors would not be classified as cytokines, though TGF is an exception. Rather an imprecise term. Chemokines are a subset of cytokines.
(29 Sep 1997)
beta-adrenergic receptor blocking agent A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable.
Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker.
(05 Mar 2000)
beta-adrenergic receptor kinase <enzyme> Cyclic-AMP protein kinase which specifically phosphorylates the agonist-occupied form of beta-adrenergic receptor
Registry number: EC 2.7.1.-
Synonym: beta-ar kinase, beta-adrenergic receptor kinase 1, g-protein-coupled receptor kinase 2, grk2 (kinase), beta-adrenergic receptor kinase 2, beta-ar kinase 2
(26 Jun 1999)
gene rearrangement, beta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors.
(12 Dec 1998)
genes, T-cell receptor beta DNA sequences encoding the beta chain of the T-cell receptor. The genomic organization of the tcr beta genes is essentially the same in all species and is similar to the organization of ig genes.
(12 Dec 1998)
TGF-beta receptor protein kinase <enzyme> Belongs to the receptor-type serine-threonine kinase subfamily; from chick embryo, related to type II receptor for tgf-beta; 502 aa residues, mw 56,766 da; aa sequence given in first source
Registry number: EC 2.7.1.-
Synonym: tgf-beta rpk, rpk-1, rpk-2
(26 Jun 1999)
gamma subunit, cGMP phosphodiesterase <enzyme> Isolated from canine retinal rod photoreceptor cells; genbank u49359
Registry number: EC 3.1.14.-
Synonym: pde-gamma, pdegamma, cgmp-pde gamma subunit
(26 Jun 1999)
glycoprotein hormones, alpha subunit A non-covalently bound subunit of the glycoprotein hormones tsh, fsh, lh, and hcg which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uraemia and malignant tumours. The alpha subunit may be involved directly in recognition of certain receptors.
(12 Dec 1998)
ribulose-1,5-bisphosphate carboxylase-oxygenase large subunit epsilonN-methyltransferase <enzyme> An aspect of EC 2.1.1.43; trimethylates lys-14 of rubisco
Registry number: EC 2.1.1.-
Synonym: rubisco lsmt, rubisco large subunit lysine n-methyltransferase
(26 Jun 1999)
cholera toxin, B subunit-horseradish peroxidase <chemical> Conjugate of horseradish peroxidase and cholera toxin
Synonym: bhrp, horseradish peroxidase-cholera toxin b subunit, cholera toxin-horseradish peroxidase, horseradish peroxidase-cholera toxin, ib4-hrp
(26 Jun 1999)
phycocyanin alpha-subunit phycocyanobilin lyase <enzyme> Cleaves thioether bond attaching phycocyanobilin to the alpha subunit of phycocyanin; product of the cpce and cpcf genes of synechococcus
Registry number: EC 4.4.-
Synonym: phycocyanobilin lyase
(26 Jun 1999)
phycoerythrocyanin alpha-subunit phycobiliviolin lyase <enzyme> Shows high degree of homology to phycocyanobilin lyase
Registry number: EC 4.4.-
Synonym: phycobiliviolin lyase, pece protein, pecf protein, pec alpha-subunit phycobiliviolin lyase
(26 Jun 1999)
signal peptide p25-subunit IV cytochrome oxidase <chemical> Similar in action to melittin
Synonym: p25 presequence peptide-cytochrome oxidase, pre-ctox p25
(26 Jun 1999)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Cytokine Receptor Common beta Subunit - »õâ A receptor subunit that is a shared component of the INTERLEUKIN-3 RECEPTOR; the INTERLEUKIN-5 RECEPTOR; and the GM-CSF RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this shared beta subunit.
    Synonyms : CD131 Antigen, CSF2RB Receptor, Cytokine Receptor Common beta Chain, GM-CSF, IL-3, IL-5 Receptor Common beta-Chain, Interleukin-3, 5, GM-CSF Receptor beta Subunit, Receptors, Cytokine, Common beta Chain, betaC Interleukin Receptor Subunit, Antigen, CD131
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit
    ¾Æ´ÜÀ§;¼­ºêÀ¯´ÏÆ®(»ýüÀÔÀÚ(°íºÐÀÚ)¸¦ ÀÌ·ç´Â ±âº» ´ÜÀ§)
  • receptor
    ¼ö¿ë±â;°¨°¢±â°ü;¼ö¿ëü
  • receptor site
    ¼¼Æ÷³» ¼ö¿ë ¿µ¿ª
  • beta
    º£Å¸
  • Phi Beta Kappa
    ÆÄÀÌ.º£Å¸.Ä«ÆÄŬ·´
  • beta
    º£Å¸(±×¸®½º¾î ¾ËÆÄºªÀÇ µÑ° ÀÚ)
  • beta minus
    2·ùÀÇÇÏ;2·ùº¸´Ù Á» ¸øÇÑ
  • beta particle
    º£Å¸ÀÔÀÚ
  • beta rays
    º£Å¸¼±
  • beta rhythm
    º£Å¸¸®µë(¸ÅÃÊ 10ÀÌ»óÀÇ ³úÆÄÀÇ ¹éµ¿)
  • common
    °øÅëÀÇ,Åë»óÀÇ
  • common wealth
    ÁÖ, ¿¬¹æ
  • common-sense
    »ó½ÄÀûÀÎ
  • Common Era
    =CHRISTIAN ERA
  • common
    °øÅëÀÇ;°øµ¿ÀÇ;°øÀ¯ÀÇ;»çȸÀϹÝÀÇ;°øÁßÀÇ;°ø°øÀÇ;º¸ÅëÀÇ;¹ü»óÇÑ;ÈçÇÑ;¼­¹ÎÀÇ;Æò¹üÇÑ;Åë¼ÓÀûÀÎ;ºñ¼ÓÇÑ;¾ßºñÇÑ;ǰÀ§°¡ ¾ø´Â;°ø¾àÀÇ;Å뼺ÀÇ;Åë°ÝÀÇ;Á¾ÇÕ(°øÅë)ÀÇ;(¸¶À» µîÀÇ)°øÀ¯Áö;°ø¿ëÁö;°ø¿ø(¿ïŸ¸® ¾ø´Â Ȳ¹«Áö µî);(¸ñÃÊÁö µîÀÇ)°øÀ¯±Ç;¹Ì»ç Åë»ó¹®;=commons
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á